04.02.2015

Specializes in the treatment of cancer using radiation

Today, a diagnosis of melanoma in its early to middle stages can usually be treated successfully using laser therapy, Mohs surgery, chemotherapy, radiation therapy or a combination of one or more of these techniques.
Moles or skin lesions suspected of harboring melanoma are routinely evaluated through a procedure called a biopsy.
A pathologist examines skin biopsies to determine if they are malignant or benign and to “stage” the cancer, if it exists. By carefully removing one thin layer of skin at a time, examining the layer for evidence of cancer and either continuing to remove layers or ceasing removal means that Mohs surgery offers a high cure rate for skin cancers that does not involve removal of healthy tissue.
In addition to visiting Mayoral Dermatology for a thorough skin examination every year (or more frequently if you are at risk for developing melanoma), keeping all follow-up appointments is vital to successfully recovering from a diagnosis of melanoma. Neglecting to have a “funny-looking” mole or skin discoloration examined by a professional dermatologist because you are afraid of what may be diagnosed defeats the purpose of quickly and aggressively eliminating skin cancer in its early stages. Call us today if you suspect you may have melanoma and talk to one of our caring specialists about your fears concerning moles, lesions or other skin anomalies that have been worrying you. New York NYC Crime Bronx Brooklyn Manhattan Queens Education Weather Obituaries Sports Yankees Mets Giants Jets Knicks Nets Rangers Islanders Football Basketball Baseball Hockey Soccer College High School The Score More Sports News Crime U.S.
Follow Us Facebook Twitter Instagram Pinterest YouTube Subscribe Follow UsNewsletter App Subscriptions Subscribe Get Our Newsletter A daily blend of the most need-to-know Daily News stories, delivered right to your inbox.
Sheryl Green, a radiation oncologist and co-director of the radiosurgery program at Mount Sinai Medical Center, specializes in using radiation therapy to eradicate breast cancer tumors and the microscopic cancer cells that can linger after tumors are removed. For women with breast cancer who choose not to have a full mastectomy, breast-conserving surgery is followed by radiation therapy. When lumpectomy and radiation are used together, they have the same cure rate as mastectomy. Radiation therapy is delivered by machines called linear accelerators, which are designed specifically for fighting cancer. The vast majority of women with breast cancer are treated with external beam radiation, in which the beam comes from a machine and is directed into the body.
Breast-conserving surgery seeks to remove the tumor and a margin of tissue around it while leaving the healthy part of the breast intact.
Most women receive radiation doses on a daily basis, Monday through Friday, for three to six weeks, depending on factors like their age and the pathology of their tumor.
Radiation treatments are painless a€” in fact, patients only know when the X-ray starts and stops because the machine makes a subtle noise. According to a vast global study by the Early Breast Cancer Trialistsa€™ Collaborative Group, using radiation after a breast-conserving surgery like lumpectomy reduces the risk of recurrence from 35% to 20% in women with early stage breast cancer. Potential lingering changes, like reddening or darkening, can continue to improve over the coming months and years. Researchers are also investigating whether some women could benefit from partial breast radiation, which would deliver radiation only to the tumor bed instead of the whole breast.
Go to a radiation oncology facility which has been audited and accredited by the American College of Radiology, and make sure that the accreditation is current.
Simple steps you can take include showering with a gentle soap that is fragrance-free, using a fragrance- and aluminum-free deodorant, and not shaving under your arms. For many women, that means wearing a different bra a€” one without an underwire a€” or wearing a camisole or undershirt instead of a bra.
Many women are surprised to learn that the longtime local recurrence rates are relatively similar for women receiving mastectomy or breast-conserving surgery followed by radiation. Hair loss can be induced by therapeutic drugs and other medical causes or due to heredity, hormones or nutrition. MaryAnne Studios specializes in custom hair restoration and replacement, using advanced techniques and a proven methodology. If you choose a human hair system, we will provide a selection of hair pieces that is handcrafted by hair artisans using 100 percent European hair to ensure perfection in fit, comfort and realistic appearance.
Our experience indicates that this ensures that your full head or partial hair replacement is lightweight, comfortable and the right match for your color, hair pattern and texture.
MaryAnne Studios offers expert customized services in a private and professional Main Line setting that will result in a positive comforting experience.
The Multidisciplinary Pancreatic Cyst Program is designed to evaluate patients with known or suspected pancreatic cysts. Ashley Salamone is a nurse practitioner with the Department of Medicine at The Johns Hopkins Hospital, and is a former Johns Hopkins surgical intensive care (SICU) nurse.
He completed his education at Bucknell College, Thomas Jefferson University, and Harvard University and his general surgery residency at Georgetown University. Mary Hodgin is a certified medical-surgical nurse with a wealth of experience, practicing at Johns Hopkins Hospital since 1977. After receiving an undergraduate degree from the University of Chicago and a medical degree from The Johns Hopkins University, Dr. During his career at Hopkins, his involvement has included graduate and post-graduate education, teaching and, most importantly, patient care. Vogelstein attended the University of Pennsylvania, where he graduated Summa Cum Laude with distinction in mathematics. Among his many honors are the Philadelphia College of Pharmacy and Science Alumni Award, The Johns Hopkins University School of Medicine Sandoz Award for Superior Academic Achievement and Contribution to Health Care, the David Israel Macht Award for Excellence in Research and the Inaugural National Brain Tumor Society Founders Award.
Melanoma occurs when damage to skin cell DNA caused by ultraviolet radiation, genetics or other extraneous factors triggers abnormally accelerated cell reproduction.
Shave biopsies are frequently used on suspect moles or lesions for the purpose of obtaining a very thin slice of skin containing elements from the epidermis and dermis.
Staging is based on how deep the melanoma has penetrated into skin layers, its size and if it has metastasized, or spread to other parts of the body, especially the lymph nodes.
Moreover, because of the high cure rate associated with Mohs surgery and subsequent reduction in the development of future skin cancers, Mohs is considered one of the most cost-effective treatments in comparison to other melanoma treatments.
Iriondo will apply a local anesthetic to the lesion before starting the procedure so that the area is fully numbed. Making sure that the treated area is healing properly and closely monitoring any skin changes that may indicate the presence of another melanoma is how we maintain our high rate of success in regards to providing effective treatment measures for many types of melanomas.
When melanoma is detected before it reaches Stage II, the cure rate for most people is between 90 and 100 percent.
Sheryl Green says radiation targets cancer cells while sparing the surrounding normal tissue. Another option is internal radiation, or brachytherapy, which temporarily implants radioactive material at the tumor site. On day one, the radiation technician will ensure that the positioning, targeting and quality assurances measures are exactly right. Although a large part of the population buys based on the lowest price, they look for more nice designs and systems Infotainment to last…. We begin with individual measurement and then create a restoration specifically for your needs. The clinic is committed to a comprehensive one week evaluation incorporating all the resources available for the education, diagnosis, treatment and research of pancreatic cancer. Manos is a Physician Assistant with the Department of Surgery at The Johns Hopkins Hospital. Anne Marie Lennon is an Associate Professor of Gastroenterology at The Johns Hopkins University School of Medicine in Baltimore, Maryland USA. Lennon is accredited in General Internal Medicine and Gastroenterology certified by the Joint Royal Colleges of Physicians Training Board (JRCPTB) of the United Kingdom. Ashley obtained her Masters' Degree in Nursing from The Johns Hopkins University in 2011 and completed her training at the Johns Hopkins Hospital and surrounding Baltimore institutions.
Nita Ahuja is a Professor of Surgery, Oncology and Urology at the Johns Hopkins University School of Medicine and the Jack Handelsman Professor in Abdominal Surgery.
Ahuja received her medical school degree from Duke University followed by general surgery training at Johns Hopkins University.
Ahuja runs a highly productive research laboratory that is focused on development of biomarkers for early detection of cancers and developing novel therapies for cancer. Martin Makary is Professor of Surgery at Johns Hopkins and specializes in laparoscopic pancreas surgery and directs the Laparoscopic Pancreas Surgery Program at Johns Hopkins.
He then completed advanced training in pancreas surgery at Johns Hopkins before joining the faculty as a GI surgeon. Jin He is an Assistant Professor of Surgery at the Johns Hopkins University School of Medicine. She received her Bachelor of Science in Nursing Degree from University of Maryland in 2003, and her Masters in Nursing Informatics in 2008. The faculty of The Department of Pathology integrate the most advanced diagnostic technologies with translational research to provide cutting edge diagnostic excellence. Hruban has authored over 600 peer-reviewed manuscripts and five books including the standard textbook on pancreatic pathology (the AFIP Fascicle on Tumors of the Pancreas) and the World Health Organization "blue book"? on tumors of the digestive tract. Hruban has received a number of awards including the Arthur Purdy Stout Prize for significant career achievements in surgical pathology, the Ramzi Cotran Award from the United States and Canadian Academy of Pathology, the PanCAN Medical Visionary Award, the Ranice W.
Hruban's research are to understand the noninvasive precursor lesions from which invasive pancreatic cancers develop (PanINs and IPMNs), why pancreatic cancer aggregates in some families, and the pathologic ramifications of genetic alterations in the pancreas. Syed Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine and The Johns Hopkins Hospital in Baltimore, Maryland, USA.


Fishman's clinical and research interests have focused on medical imaging with specific emphasis on 3-Dimensional Imaging and Computed Tomography. Fishman's work in CT has spanned the past 30 years and has resulted in over 1000 peer-reviewed publications; he has also been the author or co-author of 8 textbooks.
Fishman was recognized for his excellence in education and teaching when he received three Aunt Minnie Awards: as Outstanding Educator in 2002 and 2007, and as Outstanding Researcher in 2004. Atif Zaheer is an assistant professor in the Department of Radiology at the Johns Hopkins University.
Zaheer is actively involved in research and education and believes in a multidisciplinary approach for evaluation of disease. Bernadette Cullen is an Assistant Professor of Psychiatry with the Department of Psychiatry and Behavioral Sciences at the School of Medicine and with the Department of Mental Health at the School of Public Health.
Kenneth Kinzler is a Professor of Oncology at The Sidney Kimmel Comprehensive Cancer Center (SKCCC) at the Johns Hopkins University School of Medicine. Nickolas Papadopoulos is internationally known as a co-?discoverer of the genetic basis of the predisposition to hereditary nonpolyposis colon cancer (HNPCC), one of the most common hereditary forms of cancer. Laura Wood is an Assistant Professor in the Department of Pathology, Division of Gastrointestinal and Liver Pathology at the Johns Hopkins University School of Medicine. Rachel Karchin is an Associate Professor in the Department of Biomedical Engineering at Johns Hopkins University.
Marco Dal Molin is a post-doctoral research fellow in the Sol Goldman Pancreatic Cancer Research Center and serves as the Coordinator for a large multi-center international study on early detection of pancreatic cystic neoplasms (NCT02110498). Manuel Iriondo of Mayoral Dermatology in Coral Gables specializes in Melanoma diagnosis and treatment. Malignant tumor formations associated with melanoma are almost always in the form of moles, irregularly shaped skin lesions or ulcers. Excisional or incisional biopsies are two other commonly performed biopsies indicated by what your doctor has found following close examination of the mole or lesion. Stage 0 (melanoma in situ) is the least serious of a melanoma diagnosis and indicates that cancer cells have remained on the top layer of the skin. Skin cancers benefiting from Mohs include basal cell and squamous cell carcinomas in addition to larger melanomas that present irregular borders and are located where preservation of healthy tissue is important—mouth, eyes, nose and hands, for example. Patients are made as comfortable as possible during the treatment and post-operative care instructions involve resting, restricting physical activity and keeping the area as clean as possible. Treatments such as Mohs surgery represents one of the most uncomplicated and often painless methods that can rid your body of cancer and give you a clean bill of health. The synthetic systems are also completely customized, and offer a level of fit, comfort and appearance previously not achieved by products in this category. Lindsey is the Clinical Coordinator of The Johns Hopkins Multidisciplinary Pancreatic Cyst Program. She is the founder and Director of the Multidisciplinary Pancreatic Cyst Clinic at Johns Hopkins University. She is a Fellow of the American Society of Gastrointestinal Endoscopy and a Fellow of the Royal College of Physicians of Ireland.
Wolfgang is the Chief of Hepatobiliary and Pancreatic Surgery at the Johns Hopkins Hospital and Professor of Surgery, Pathology and Oncology at Johns Hopkins Univesrity School of Medicine. She then completed advanced fellowship training in surgical oncology at Johns Hopkins before joining the faculty at Johns Hopkins as a surgical oncologist in 2003.
Her laboratory has identified promising markers for early detection of pancreas cancer using blood samples. His clinical interests include minimally-invasive surgery for abdominal tumors and the association of frailty and risk in older surgical patients. Weiss is an Assistant Professor of Surgery at the Johns Hopkins University School of Medicine. He is board-certified in general surgery and fellowship-trained in complex surgical oncology and hepatopancreatobiliary (liver, pancreas and bile ducts) surgery. Employing her background as a senior staff nurse, Mary brings her understanding of inpatient concerns to complement her role as a triage nurse and research coordinator in the pancreas cyst program.
We have extensive expertise in both Surgical Pathology (the interpretation of biopsies and surgically resected materials), and in Cytopathology (the interpretation of cells that are removed from tissues by fine needle aspiration).
Hruban is the Director of the Department of Pathology, and Professor of Pathology and Oncology at The Johns Hopkins University School of Medicine in Baltimore, Maryland USA.
He then completed a fellowship in surgical pathology at Memorial Sloan-Kettering Cancer Center in New York and returned to join the faculty at Johns Hopkins in 1990. He is recognized by the Institute for Scientific Information as a Highly Cited Researcher and by Essential Science Indicators as the most highly cited pancreatic cancer scientist. He is also the Director of the Division of Cytopathology and Director of the Cytopathology fellowship training program.
Fishman received his bachelor's degree in 1973 and his medical degree in 1977 from the University of Maryland. He was involved from the beginning in the development of 3D Imaging through his work with Pixar, which was a spin-off from LucasFilms in San Rafael, California.
Fishman has been a sought-after speaker worldwide for many Continuing Medical Education (CME) courses and has given many named lectures. Radiologists throughout the world choose the recipients of the annual Aunt Minnie Awards and Dr.
He is clinically active in cross-sectional imaging of the body using CT, MRI and Ultrasound. His discovery that mutations in the mismatch repair genes (MSH2, MLH1, MSH6, and PMS2) predispose to HNPCC had important ramifications for the understanding and molecular classification of cancers that have a very high rate of certain type of mutations.
His research focuses on the integration of clinical features and molecular tests for the differential diagnosis of pancreatic cysts. Although melanoma is not the most commonly diagnosed form of skin cancer, it is the most dangerous because it is capable of spreading to other parts of the body.
An excisional biopsy means the entire area of concern is removed surgically and sent to a laboratory for further evaluation. Stage I, II and III are considered treatable melanomas that differ from each other due to thickness of the tumor and degree of infiltration into the lymph nodes.
Mohs techniques are also used on melanomas that have re-emerged following removal with PDL therapy or a total excision procedure. Lindsey obtained her Masters Degree in Physician Assistant Sciences from Gannon University in 2009. After receiving a medical degree from the Royal College of Surgeons in Ireland, and a PhD from University College Dublin, Dr. She has authored over 70 peer-reviewed papers, 21 book chapters and is the co-editor of the textbook Gastrointestinal Endoscopy in Practice. Ahuja is a board-certified and fellowship-trained surgical oncologist who specializes in treatment of cancers of the gastrointestinal system including pancreas, stomach, colon and rectum as well as retroperitoneal sarcomas. Makary is the Mark Ravitch Chair in Gastrointestinal Surgery and an active researcher in both minimally-invasive surgery and health services research.
He is board-certified in general surgery and dual fellowship-trained in both complex surgical oncology and hepatopancreatobiliary (liver, pancreas and bile ducts) surgery. He earned his medical degree from Beijing Medical University and performed postdoctoral oncology research at the UT Southwestern Medical Center. He also is the Director of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins University.
Brufsky Award of Excellence in Clinical Research for Pancreatic Cancer, the Frank Netter Award for Special Contributions to Medical Education, the Johns Hopkins University Distinguished Alumni Award, the Team Science Award from the American Association for Cancer Research, the Ruth Leff Siegel Award for Pancreatic cancer Research, and five teaching awards from the Johns Hopkins School of Medicine.
Hruban has applied molecular genetics to the study of noninvasive precursor lesions in the pancreas and to patients with familial pancreatic cancer. His major interest is focused on clinicopathologic analyses by attempting to address diagnostic issues and prognostic factors, primarily based on aspiration cytopathology of pancreas and thyroid.
He has coordinated more than 100 CME courses for Johns Hopkins School of Medicine, including the CT Cutting Edge Course for the past 25 years.
These discoveries lead to the development of diagnostic tests for the presymptomatic diagnosis of individuals with HNPCC, invaluable information for the management of the families with HNPCC.
Part of his research focuses on the development of novel methods for predicting the influence of genetic alteration on human health and disease. In addition, he is exploring the use of genetic tests for the early diagnosis of pancreatic cancer.
Alternately, an incisional biopsy involves removing only a small piece of tissue from the mole or lesion for microscopic examination. Stage IV melanoma is rarely diagnosed but represents the worst stage due to metastization of the cancer.
Lindsey completed her clinical training at The University of Pittsburgh Medical Center and The Johns Hopkins Hospital in 2009.
Lennon continued her residency training in internal medicine at the Mater Hospital, Dublin and the Cleveland Clinic, Cleveland, Ohio. She has given multiple talks at national and international meetings on the management of patients with pancreatic cysts. Neumann Professor of Pancreatic Cancer Research and a member of the Miller-Coulson Academy of Clinical Excellence.


Ahuja is recognized internationally for her expertise in the management of complex gastrointestinal cancers.
She currently also has multiple ongoing national and international trials focused on novel cancer therapies.
Makary speaks nationally on new technology in surgical care, quality and safety in medicine, and health policy. He earned his medical degree from Jefferson Medical College and performed oncology research at the Children's Hospital of Philadelphia.
He was then trained in general surgery at the Johns Hopkins Hospital and completed clinical fellowships at the Johns Hopkins Hospital in both surgical oncology and hepatopancreatobiliary surgery. A better understanding of these lesions and families may provide an avenue for the early detection of pancreatic cancer. Ali did his Anatomic and Clinical Pathology residency at North Shore University Hospital-Cornell University Medical College in New York. His latest work is the editorship of the highly acclaimed book on the new Thyroid Bethesda System, which has taken him to over 15 countries for well over 30 invited lectures in the last two years. Fishman completed a Fellowship in Computed Tomography in 1980 at Johns Hopkins Hospital and joined The Russell H. Fishman continued to help develop 3D imaging and has been a leader in the development of interactive 3D rendering. His research interests include imaging of tumors and inflammatory disorders of the pancreas. Vogelstein completed a post-doctoral fellowship at the National Cancer Institute, focusing on the development of new techniques in molecular biology. He is well renowned for his development of diagnostic tests and he is considered an expert in cancer diagnostics. From this work, he has isolated and published many new genetic markers of disease progression and so-called "actionable" targets, which are markers of drug response and therapeutic intervention. He obtained his medical diploma at the University of Verona, School of Medicine in Italy, and completed a general surgery residency in the Department of Surgery – Pancreas Institute, also at the University of Verona.
She then completed a Fellowship in Gastroenterology in Edinburgh, United Kingdom, followed by a two year Advanced Endoscopy Fellowship in endoscopic ultrasound and ERCP at Johns Hopkins. She has published extensively in both clinical and basic science journals and has written several books on management of cancer including the book Living with Pancreas Cancer for patients and their families.
He trained in general surgery at the Johns Hopkins Hospital and completed a research fellowship at the Massachusetts General Hospital in immunology. Hirose specializes in hepatopancreatobiliary surgery with an interest in benign and malignant conditions of the liver, bile duct and pancreas, as well as minimally invasive surgical techniques. His clinical interests include both benign and malignant tumors of the stomach, liver, pancreas, bile ducts, and gallbladder. This was followed by two fellowships; one in Oncologic Surgical Pathology at the Memorial Sloan-Kettering Cancer Center in New York and the other one in Clinical Cytopathology at The Johns Hopkins Hospital. Morgan Department of Radiology and Radiological Science at Johns Hopkins in 1981 as an Assistant Professor.
Today, this is a major part of state-of-the-art imaging with a significant impact on patient care and management. He returned to Johns Hopkins as an Assistant Professor in Oncology, and is now Clayton Professor of Oncology and Pathology.
He not only developed diagnostics at the bench, but as a Chief Scientific Officer of a startup diagnostics company he lead a team in the development and commercialization of a novel diagnostic method applicable to any gene tic disease. These genetic markers can help physicians more accurately diagnose the stage or type of a patients cancer using noninvasive techniques, as well as inform safe and effective treatment protocols.
Lennon's research is centered on developing better tools, and improving care for patients with pancreatic cysts. Wolfgang specializes in the care of patients with pancreatic cancer and pancreatic cysts and is among the highest volume pancreatic surgeons in the country. He completed clinical fellowships at Memorial Sloan-Kettering Cancer Center in both surgical oncology and hepatopancreatobiliary surgery. Hruban has made these "apps"? free to the pancreas community with the goal of i mproving the practice of pancreas pathology around the world. His expertise also includes illustrating the emerging role of high-resolution digital photo imaging, whole slide virtual microscopy and remote telepathology in education, research and routine diagnostic pathology.
This website is currently used each month by over 50,000 medical professionals from more than 100 countries. James Hospital, Dublin and completed research and clinical fellowships at Johns Hopkins Medical Institutions. He was a research fellow in cancer genetics at Johns Hopkins from 1995-1998 He joined the faculty at Johns Hopkins in 1998 and is Director of the Pancreatic Cancer Early Detection Laboratory. These approaches fall under the umbrella of "personalized medicine", where diagnosis and treatment are based on each patients uniquely individual genetic signatures.
He routinely performs complex pancreatic operations including the standard Whipple Operation, laparoscopic and robotic Whipple Operations and Whipple Operations requiring vascular resection and reconstructions.
His clinical interests include both benign and malignant tumors of the pancreas, liver, bile ducts, and gallbladder. He has been instrumental in creating novel web-based tutorials, podcasts, and house staff performance evaluation tools to more sophisticated virtual photomicroscopy in diagnostic pathology.
Fishman's interests in computed tomography have spanned the era from early scanners that took 10 seconds per slice, to the scanners of today where the studies are done in less than 1 second. The site has been honored by numerous organizations for its excellence and is one of the sites chosen sites for Medscape. He was part of the interdisciplinary team that was first to sequence all of the protein coding genes and determine genetic alterations and construct expression profiles in multiple tumors of four different common human cancers.
His research interests include the early detection of pancreatic neoplasia through molecular markers, pancreatic cancer screening, familial pancreatic cancer susceptibility gene discovery and identifying genetic and epigenetic alterations that predict response to therapy. Lennon specializes in caring for patients with pre-cancerous lesions of the pancreas or pancreatic cancer. He has particular interest in caring for patients with cystic lesions of the pancreas and is considered one of the world's experts having published over 200 scientific articles related to pancreatic cysts, pancreatic cancer and pancreatic surgery. His research team is one of the world's leading groups in developing new techniques and technologies, whether in visualization or post-processing tools. Vogelstein also holds a joint appointment in Molecular Biology and Genetics at JHU and is an Investigator of the Howard Hughes Medical Institute. Most recent efforts have involved the identification of genetic alterations that drive tumorigenesis using a new generation of sequencing technologies. He is the author of over 200 peer reviewed publications, holder of several patents and was recognized by Essential Science Index as the 6th most highly cited pancreatic cancer scientist in the decade between 1996-2006. He is a member of the International Consensus Guideline Committee that produced the most widely used guidelines in caring for patients with a pancreatic cyst.
Monastra Foundation, The Michael Rolfe Pancreatic Cancer Foundation, and The Lustgarten Foundation.
Ali serves on the editorial board of key scientific journals and has major appointments in several professional Pathology organizations including, membership of the executive board and chairmanship of the scientific program committee of the American Society of Cytopathology.
His work has spawned over 100 patent applications, most focused on the use of genetic approaches to improve the diagnosis and management of patients with cancers and other serious diseases.
A noteworthy discovery he has made in the recent year include the identification of novel, signature mutations in ovarian clear cell carcinomas and pancreatic neuroendocrine tumors.
In addition he runs a basic and translational science lab that is investigating the early genetic changes of IPMN - the type of cysts that can lead to pancreatic cancer.
These mutations are in genes that control epigenetic changes in the cell, thus, developing the paradigm that epigenetic changes in cancer cells are controlled by genetic changes. This work has provided new insights into the pathogenesis of these tumor types as well as new diagnostic strategies.
Wolfgang obtained his medical degree from Temple University School of Medicine and residency training in General Surgery at Penn State Milton S. Currently, he is focused on translating the genetic information derived from c ancer genome analyses to clinical applications in early detection, diagnosis and monitoring of cancer.
Wood then went on to complete residency in Anatomic Pathology (serving as Chief Resident in her final year) and fellowship in Gastrointestinal and Liver Pathology at The Johns Hopkins Hospital. Now, she is leads her own basic science laboratory focused on genetic characterization of pancreatobiliary cancers and their precursor lesions. Wolfgang obtained a PhD degree in Biochemistry, also from Temple University School of Medicine.
This ongoing collaborative study brings together families from over 10 familial pancreatic cancer registries with the goal of identifying pancreatic cancer predisposition genes through whole genome sequencing. Wolfgang has completed a research fellowship in surgical oncology from Penn State and a clinical fellowship in gastrointestinal surgery at Johns Hopkins. Klein is also a member of the steering committee of the Pancreatic Cancer Case-Control Consortium.



Herbal treatment for joint and muscle pain
Traditional chinese medicine hot and cold foods
Kantar health cancer impact assessment


Comments to «Specializes in the treatment of cancer using radiation»

  1. Tenha_qizcigaz writes:
    Cures that can treat affected person visits, within a 5-yr period before the.
  2. kama_189 writes:
    The acupuncture group had considerably lower prostate better than I had been pushing.
  3. RIJIY writes:
    TCM treatment technique is acupuncture medicine And Medical.
  4. AlyoskA_LovE writes:
    Efficacy of acupuncture for technique, which helps to suppress appetite and.